DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20162936

Role of inflammation as reflected by serum hsCRP and ferritin level in major depressive disorder

Soma Gupta, Sharmistha Chatterjee, Sanjoy Kunti, Kanika Mandi Chowdhury, Subhendu Dutta, Saswati Nath, Harendra Nath Das

Abstract


Background: The relationship between depression and inflammation has been strengthened by different studies for which Immune Cytokine Mechanism has been proposed to explain pathogenesis of depression.

Methods: The role of inflammation in major depressive disorder (MDD) has been evaluated in this study among 101 patients suffering from MDD along with 106 age and sex matched control subjects. Two well known acute phase reactant proteins namely hsCRP and Ferritin were assayed in all study subjects by Enzyme Immuno Assay method.

Results: Concentration of hsCRP in serum was found to be significantly increased in all patients suffering from MDD whereas Ferritin level was found to be significantly decreased in male MDD subjects only (male: 70.6 ng/ml±53.54 ng/ml in MDD vs 100.16 ng/ml±39.93 in controls; female: 38.43 ng/ml±11.2 in MDD vs 39.93 ng/ml±15.0 in controls). There was no significant alteration of the parameters among different grades of MDD. The possibility of these two parameters to be used as biomarkers has also been evaluated by ROC curve.

Conclusions: The significant change in hsCRP & Ferritin which is not associated with grade wise alteration suggests that probably inflammation is the early event which causes depression. Therefore no gradual change is observed with increase in severity of the disease. hsCRP can be used as a biomarker of Inflammation in MDD cases.


Keywords


MDD, Inflammation, Acute phase reactant, Ferritin, hsCRP

Full Text:

PDF

References


Lopez AD, Mathers CD, Ezzati M. Global burden of disease and risk factors. Washington: The World Bank. 2006.

Nierenberg AA, Dougherty D, Rosenbaum JF. Dopaminergic agents and stimulants as antidepressant augmentation strategies. J Clin Psychiatry. 1998;59:60-3.

Hoen P, Kupper N, De Jonge P. Depression and cardiovascular disease progression: epidemiology, mechanisms and treatment. In: Hjemdahl P, Rosengren A, Steptoe A, eds. Stress and cardiovascular disease. London, United Kingdom: Springer. 2012:211-33.

Anderson RJ, Freedland KE, Clouse RE. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069-78.

Hart BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 1988;12(2):123-37.

Hamer M, Batty GD, Marmot MG, Singh-Manoux A, Kivimäki M. Anti-depressant medication use and C-reactive protein: results from two population-based studies. Brain Behav Immun. 2011;25(1):168-73.

Maes M, Van de Vyvere J, Vandoolaeghe E, Bril T, Demedts P, Wauters A, et al. Alterations in iron metabolism and the erythron in major depression: further evidence for chronic inflammatory process. Journal of Affective Disorders. 1996;40:23-33.

Huang TL, Lee CT. Low serum albumin and high ferritin levels in chronic hemodialysis patients with major depression. Psychiatry Res. 2007;152(2-3):277-80.

Bech P, Rasmussen NA, Olsen R, Noerholm V, Abildgaard W: The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Dis. 2001;66:159-64.

Goldberg D. Identifying psychiatric illnesses among general medical patients. British Medical Journal. 1985;291:161-2.

Aziz N, Fahey JL, Detels R, Butch AW. Analytical Performance of a Highly Sensitive C-Reactive Protein-Based Immunoassay and the Effects of Laboratory Variables on Levels of Protein in Blood. Clin Diagn Lab Immunol. 2003;10(4):652-7.

Forman DT, Parker SL. The measurement and interpretation of serum ferritin. Ann Clin Lab Sci. 1980;10(4):345-50.

Wichers M, Maes M. The psychoneuroimmunopathophysiology of cytokine induced depression in humans. Int J Neuropsychopharmacol. 2002;5(4):375-88.

Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24-31.

Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry JM, Kotowicz MA. Association of high-sensitivity C-reactive protein with de novo major depression. The British Journal of Psychiatry. 2010;197(5):372-7.

Vetter ML, Wadden TA, Vinnard C, Moore RH, Khan Z, Volger S, et al. Gender differences in the relationship between symptoms of depression and high-sensitivity CRP. Int J Obes (Lond). 2013;37,1:S38-43.

Wium-Andersen MK, Orsted DD, Nielsen SF, MScEE, Nordestgaard BG. Elevated C - reactive protein Levels, Psychological Distress, and Depression in 73 131 Individuals. JAMA Psychiatry. 2013;70(2):176-84.

Shariatpanaahi MV, Shariatpanaahi ZV, Moshtaaghi M, Shahbaazi SH, Abadi A. The relationship between depression and serum ferritin level. European Journal of Clinical Nutrition. 2007;61:532-5.

Hunt JR, Penland JG. Iron status and depression in premenopausal women: an MMPI study. Minnesota Multiphasic Personality Inventory. Behav Med. 1999;25(2):62-8.

Baune BT, Neuhauser H, Ellert U, Berger K. The role of the inflammatory markers ferritin, transferrin and fibrinogen in the relationship between major depression and cardiovascular disorders - The German Health Interview and Examination Survey. Acta Psychiatrica Scandinavica. 2010;121(2):135-42.

Beard JD, Connor JR, Jones BC. Iron in the brain. Nutr Rev. 1993;51:157-70.